Search

Search Constraints

You searched for: Author/Creator Musolino, A.

Search Results

1. 1849 Italian observational study of Eribulin Mesylate in patients with advanced breast cancer: ESEMPiO study. (September 2015)

4. Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study. (October 2017)

5. Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study. (December 2019)

6. Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study. (January 2018)

7. Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer. (October 2022)

9. RISK OF HEMOLYMPHOPOIETIC NEOPLASM BEFORE AND AFTER THYROID CANCER. A POPULATION‐BASED STUDY IN ITALY, 1998‐2012. (17th June 2021)

10. RZISK OF HEMOLYMPHOPOIETIC NEOPLASM BEFORE AND AFTER THYROID CANCER. A POPULATION‐BASED STUDY IN ITALY, 1998‐2012. (17th June 2021)